Otis W Brawley's Net Worth

$530 Thousand

Estimate Recalculated Jun 23, 2025 04:11PM EST

Who is Otis W Brawley

Otis W Brawley does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AGILENT TECHNOLOGIES, INC., INCYTE CORP, Lyell Immunopharma, Inc., PDS Biotechnology Corp, and THERAGENICS CORP.

SEC CIK

Otis W Brawley's CIK is 0001213029

Past Insider Trading and Trends

2023 was Otis W Brawley's most active year for acquiring shares with 7 total transactions. Otis W Brawley's most active month to acquire stocks was the month of May. 2004 was Otis W Brawley's most active year for disposing of shares, totalling 10 transactions. Otis W Brawley's most active month to dispose stocks was the month of January. 2024 saw Otis W Brawley paying a total of $358,081.44 for 156,775 shares, this is the most they've acquired in one year. In 2005 Otis W Brawley cashed out on 10,855 shares for a total of $42,877.25, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AGILENT TECHNOLOGIES, INC.

Investor
Updated Mar 19, 2024
Form 4
43.15%
2.43K
$147.48
$358.08K
Mar 19, 2024
8.06K
Grant
Mar 15
Form 4
75.29%
2.40K
$136.82
$328.23K
Mar 20, 2023
5.59K
Grant
Mar 16
Form 4
442.20%
2.58K
$136.82
$353.27K
Mar 21, 2022
3.17K
Grant
Mar 17
Form 4
583.00
$162.16
$94.54K
Nov 19, 2021
583.00
Grant
Nov 18
Form 3
Nov 19, 2021
Showing 5 results

INCYTE CORP

Investor
Updated Jun 14, 2024
Form 4
259.94%
15.35K
Jun 14, 2024
21.25K
Grant
Jun 12
Form 4
405.97%
13.80K
Jun 16, 2023
17.20K
Grant
Jun 14
Form 4
897.85%
11.27K
Jun 17, 2022
12.52K
Grant
Jun 15
Form 4
7.17K
Sep 29, 2021
7.17K
Grant
Sep 27
Form 3
Sep 29, 2021
Showing 5 results

Lyell Immunopharma, Inc.

Investor
Updated Jun 17, 2024
Form 4
130.00K
Jun 17, 2024
130.00K
Grant
Jun 14
Form 4
55.00K
Sep 08, 2023
55.00K
Grant
Sep 08
Form 4
65.00K
Jun 20, 2023
65.00K
Grant
Jun 16
Form 4
65.00K
Jun 10, 2022
65.00K
Grant
Jun 08
Form 3
Jun 16, 2021
Showing 5 results

PDS Biotechnology Corp

Investor
Updated Jun 25, 2024
Form 4
9.00K
Jun 25, 2024
9.00K
Grant
Jun 24
Form 4
9.00K
Jul 17, 2023
9.00K
Grant
Jul 14
Form 4
9.00K
Jun 29, 2022
9.00K
Grant
Jun 28
Form 4
9.00K
Jun 17, 2021
9.00K
Grant
Jun 17
Form 4
9.00K
Nov 06, 2020
9.00K
Grant
Nov 03
Form 3
Nov 06, 2020
Showing 6 results

THERAGENICS CORP

Investor
Updated May 18, 2007
Form 4
14.13%
5.00K
May 18, 2007
40.40K
Grant
May 17
Form 4
16.45%
5.00K
May 10, 2006
35.40K
Grant
May 09
Form 4
19.69%
5.00K
May 12, 2005
30.40K
Grant
May 10
Form 4
36.98%
41.15K
$2.79
-$627.25
Jan 27, 2005
152.40K
Options
Jan 26
Form 4
10.81%
1.00K
Nov 15, 2004
10.25K
Grant
Nov 10
Form 4
19.30%
26.25K
$3.62
-$25.37K
Feb 10, 2004
162.25K
Options
Feb 06 - Feb 06
Form 4
1.00K
Nov 13, 2003
1.00K
Grant
Nov 11
Form 4
May 15, 2003
Form 4
May 15, 2003
Showing 9 results